Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Heymut Omran, MD
University Hospital Muenster
Principal Investigator - John Matthews, MBBS, MCRP, PhD
ReCode Therapeutics, Inc.
Study Chair - Kim G Nielsen, Dr Med Sci
Rigshospitalet, Denmark
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Copenhagen University Hospital - Rigshospitalet
Copenhagen, Denmark
- Münster University Hospital, Albert-Schweitzer-Campus 1
Münster, North Rhine-Westphalia, Germany
- Unc
Chapel Hill, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Oct 2024
- Primary completion
- 30 Jun 2025
- Completion
- 10 Feb 2026
- Last update posted
- 30 Apr 2026
- Registered enrollment
- 14
- Registry id
- NCT06633757
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.